Yet, although most patients with T1DM can control their blood glucose levels through insulin therapies, there is a need for some additional therapies to support the control of blood glucose levels, minimize the risk of hypoglycemia, and help patients recover their blood glucose control in patients who struggle to maintain healthy levels despite receiving a consistent insulin therapy. This evidence concerns the gene INS and Hypoglycemia.